Imunon Inc. (NASDAQ: IMNN)
$1.47
+0.0600 ( +4.25% ) 72.4K
Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases.
Market Data
Open
$1.47
Previous close
$1.41
Volume
72.4K
Market cap
$14.15M
Day range
$1.41 - $1.50
52 week range
$0.48 - $2.00
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | May 14, 2024 |
8-k | 8K-related | 15 | May 13, 2024 |
10-q | Quarterly Reports | 66 | May 13, 2024 |
8-k | 8K-related | 16 | May 08, 2024 |
ars | Annual reports | 1 | Apr 29, 2024 |
def | Proxies and info statements | 1 | Apr 26, 2024 |
8-k | 8K-related | 15 | Apr 11, 2024 |
8-k | 8K-related | 15 | Mar 28, 2024 |
10-k | Annual reports | 97 | Mar 28, 2024 |
4 | Insider transactions | 1 | Mar 18, 2024 |